| Literature DB >> 28218702 |
Amélia M G Rodrigues1,2,3, Denise O Guimarães4, Tatiana U P Konno5, Luzineide W Tinoco6, Thiago Barth7, Fernando A Aguiar8,9, Norberto P Lopes10, Ivana C R Leal11, Juliana M Raimundo12, Michelle F Muzitano13.
Abstract
The aim of this research was to perform a phytochemical study of the methanol leaves extract of T. guianensis (MET) guided by vasodilatory and antioxidant activities. The chemical profile of MET and the ethyl acetate fraction (EA fraction) was determined by HPLC-UV-MS and EA fraction guided fractionation by reverse-phase chromatography. The vasorelaxant effects of MET, fractions, sub-fractions and constituents were assessed on rat aorta pre-contracted with phenylephrine. Antioxidant activity was evaluated by using a DPPH assay. The results show that MET-induced vasodilation was dependent on NO/cGMP; and that the PI3K/Akt pathway seems to be the main route involved in eNOS activation. The EA fraction showed greater vasodilatory and antioxidant potency and was submitted to further fractionation. This allowed the isolation and characterization of quercetin, quercetin 3-O-(6″-O-galloyl)-β-d-galactopyranoside and 1,4,6-tri-O-galloyl-β-d-glucose. Also, galloyl-HHDP-hexoside and myricetin deoxyhexoside were identified by HPLC-UV-MS. These compounds are being described for the first time for T. guianensis. 1,4,6-tri-O-galloyl-β-d-glucose and quercetin 3-O-(6″-O-galloyl)-β-d-galactopyranoside showed no vasodilatory activity. Quercetin and myricetin glycoside seems to contribute to the MET activity, since they have been reported as vasodilatory flavonoids. MET-induced vasodilation could contribute to the hypotensive effect of T. guianensis previously reported.Entities:
Keywords: Tapirira guianensis; antioxidant; aorta; flavonoid; tannin; vasodilation
Mesh:
Substances:
Year: 2017 PMID: 28218702 PMCID: PMC6155791 DOI: 10.3390/molecules22020304
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1LC-UV-MS chromatogram of the ethyl acetate fraction of the methanol extract of T. guianensis leaves.
Figure 2LC-UV-MS chromatogram of sub-fraction 4 from the ethyl acetate fraction of the methanol extract of T. guianensis leaves.
MS analyses of the T. guianensis EA fraction with emphasis on the major (254 nm chromatogram) and isolated compounds.
| Retention Time ( | Identity | Pseudomolecular Ion | Fragment | λMAX (nm) |
|---|---|---|---|---|
| 18.9 | 1,4,6-tri- | - | 467.12 (170) | 276 |
| 21.0 | quercetin 3- | 617.17 [M + H]+ | - | 263, 352 |
| 22.0 | myricetin deoxyhexoside | 465.13 [M + H]+ | 319.06 (146) | 257, 350 |
| 23.9 | quercetin pentoside | 435.12 [M + H]+ | 303.05 (132) | 256, 352 |
| 24.5 | quercetin dideoxyhesoside | 595.20 [M + H]+ | 449.13 (146) 303.06 (146) | 255, 348 |
| 31.7 | Quercetin a | 303.05 [M + H]+ | - | 255, 369 |
a Isolated compound.
MS analyses of T. guianensis EA active sub-fraction 4 with emphasis on major (254 nm chromatogram) and isolated compounds.
| Retention Time ( | Identity | Pseudomolecular Ion | Fragment | λMAX (nm) |
|---|---|---|---|---|
| 18.9 | 1,4,6-tri- | - | 467.08 (170) | 277 |
| 19.1 | galloyl-HHDP-hexoside | 633.10 [M + H]+ | - | 266 |
| 21.0 | quercetin 3- | 617.17 [M + H]+ | - | 263, 352 |
| 22.0 | myricetin deoxyhexoside | 465.13 [M + H]+ | 319.06 (146) | 261, 350 |
a Isolated compound.
Figure 3Mechanism of action of vasodilatory activity of the methanol extract of T. guianensis leaves (MET). (a) Concentration-response curves for MET in aortas with and without endothelium; (b) Effect of MET in endothelium-intact rings pretreated with L-NAME (100 μM) or ODQ (100 μM); (c) Effect of MET in endothelium-intact rings pretreated with wortmannin (300 nM); (d) Effect of MET in endothelium-intact rings pretreated with indomethacin (10 μM). Data are mean ± standard error of mean (S.E.M.) (n = 5–7). * p < 0.05 and *** p < 0.0001 compared to with endothelium.
Figure 4Effects of ethyl acetate fraction (EA fraction), sub-fractions and isolated compounds on aortic rings with endothelium. (a) Concentration-response curves for EA fraction, sub-fraction 4 and sub-fraction 5; (b) Concentration-response curves for 1,4,6-tri-O-galloyl-glucose (EA1) and quercetin 3-O-(6″-O-galloyl)-β-d-galactopyranoside (EA2). Data are mean ± S.E.M. (n = 5–6).
Antioxidant effect of MET and its fractions assessed by the DPPH assay.
| Samples | EC50 (µg/mL) |
|---|---|
| MET | 3.12 ± 0.20 a |
| HN fraction | 40.30 ± 0.39 c |
| DCM fraction | 19.83 ± 0.90 d |
| EA fraction | 5.33 ± 0.16 b |
| BT fraction | 6.05 ± 0.19 b |
| Aq fraction | 14.33 ± 0.15 e |
| Egb 761® | 22.91 ± 0.66 f |
EC50, Concentration required to induce 50% maximal response; MET, methanol extract of T. guianensis leaves; HN fraction, hexane fraction; DCM fraction, dichloromethane fraction; EA fraction, ethyl acetate fraction; BT fraction, butanol fraction; Aq fraction, aqueous fraction; Egb 761®, Ginkgo biloba extract). The results are means ± S.E.M. Statistical analyses were calculated and values with different superscript letters (a–f) are significantly different (p < 0.0001); determined by a Tukey test.
Figure 5Chemical structure of compounds isolated from T. guianensis leaves. (a) 1,4,6-tri-O-galloyl-β-d-glucose (EA1); (b) quercetin 3-O-(6″-O-galloyl)-β-d-galactopyranoside (EA2).